Healthcare Services Act: Licensing Framework for Hospital and Ambulatory Care Services & Changes to Regulatory Framework wef 26 June 2023

On 26 June 2023, the Healthcare Services Act 2020 (“HCSA”) was amended to implement the following key changes:

  1. Transitioning existing licensees offering hospital and ambulatory care services and specified services under the Private Hospitals and Medical Clinics Act (“PHMCA”) to HCSA (“Phase 2 implementation of HCSA”
  2. Enhancing the regulatory regime governing healthcare services; and
  3. Ensuring greater clarity and transparency in healthcare services advertising.

The HCSA is being implemented progressively with licensees coming onboard HCSA in three phases, with: (1) Phase 1 implemented for clinical support services (e.g. laboratory, radiological) in January 2022; (2) Phase 2 implemented for various hospital and ambulatory care services and specified services (e.g. liposuction, endoscopy) on 26 June 2023; and (3) Phase 3 to be implemented for long-term care services and other specialised and new services (e.g. preventive health) by the end of 2023.

The second and third phases set out above are introduced in the Healthcare Services (Amendment) Act 2023 (“Amendment Act”) which was passed in Parliament on 27 March 2023. The Amendment Act refines the HCSA to address developments which have an impact on the healthcare industry since the HCSA was enacted in 2020.

This Update provides a summary of the changes to the HSCA that have taken effect on 26 June 2023.

For more information, click here to read the full Legal Update.

CONTACTS

Co-Head, Medical, Healthcare & Life Sciences
Co-Head, China-Related Investment Dispute Resolution
Chairperson, Rajah & Tann Foundation
+65 6232 0416
China, Singapore,
Regional Head, Mergers & Acquisitions
Co-Head, Medical, Healthcare & Life Sciences
Partner, Rajah & Tann Singapore
Partner, Christopher & Lee Ong (Malaysia)
Executive Committee Member, Rajah & Tann LCT Lawyers (Vietnam)
+65 6232 0606
Malaysia, Singapore, Vietnam,

Country

EXPERTISE

Share

Rajah & Tann Asia is a network of legal practices based in Asia.

Member firms are independently constituted and regulated in accordance with relevant local legal requirements. Services provided by a member firm are governed by the terms of engagement between the member firm and the client.

This website is solely intended to provide general information and does not provide any advice or create any relationship, whether legally binding or otherwise. Rajah & Tann Asia and its member firms do not accept, and fully disclaim, responsibility for any loss or damage which may result from accessing or relying on this website.

© 2024 Rajah & Tann Singapore LLP. All rights reserved. Rajah & Tann Singapore LLP (UEN T08LL0005E) is registered in Singapore under the Limited Liability Partnerships Act (Chapter 163A) with limited liability.